FIGURE 3 from Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib

Paul B. Chapman, Mark Klang,Michael A. Postow, Alexander Noor Shoushtari,Ryan J. Sullivan,Jedd D. Wolchok,Taha Merghoub,Sadna Budhu,Phillip Wong,Margaret K. Callahan,Bin Zheng,Jonathan Zippin

crossref（2023）

引用 0|浏览2

暂无评分

摘要

Effect of treatment on percentage of circulating MDSCs derived from flow cytometric analysis of PBMC samples from patients treated at the 150 and 200 mg bid dose level. Dotted lines indicate times when patient was not taking phenformin. bid, twice daily.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要